日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Alpha Therapy Beyond TOC and TATE-Production, Quality Control, and In-Human Results for the SSTR2 Antagonist DOTA-LM3

超越TOC和TATE的Alpha疗法——SSTR2拮抗剂DOTA-LM3的生产、质量控制和人体试验结果

Greifenstein, Lukas; Martin, Marcel; Stephan, Sarah; Eismant, Aleksandr; Kramer, Carsten S; Landvogt, Christian; Mueller, Corinna; Rösch, Frank; Baum, Richard P

First-in-human study of an optimized, potential kit-type, SSTR antagonist (68)Ga-DATA(5m)-LM4 in patients with metastatic neuroendocrine tumors

首次人体研究:优化的潜在试剂盒型SSTR拮抗剂(68)Ga-DATA(5m)-LM4在转移性神经内分泌肿瘤患者中的应用

Zhang, Jingjing; Greifenstein, Lukas; Jakobsson, Vivianne; Zan, Elcin; Klega, Andre; Rösch, Frank; Landvogt, Christian; Mueller, Corinna; Baum, Richard P

Peptide Receptor Radionuclide Therapy (PRRT) Using Actinium-225- and Ac-225/Lutetium-177-Labeled (TANDEM) Somatostatin Receptor Antagonist DOTA-LM3 in Patients with Neuroendocrine Neoplasm: A Retrospective Study Concerning Safety and Survival

使用锕-225 和 Ac-225/镥-177 标记的(TANDEM)生长抑素受体拮抗剂 DOTA-LM3 进行肽受体放射性核素治疗 (PRRT) 治疗神经内分泌肿瘤患者:一项关于安全性和生存率的回顾性研究

Perrone, Elisabetta; Calcagni, Maria Lucia; Leccisotti, Lucia; Moretti, Roberto; Ghai, Kriti; Eismant, Aleksandr; Parkar, Tanay; Greifenstein, Lukas; Baum, Richard Paul

3BP-3940, a highly potent FAP-targeting peptide for theranostics - production, validation and first in human experience with Ga-68 and Lu-177

3BP-3940,一种用于治疗诊断的高效 FAP 靶向肽 - 生产、验证以及首次与 Ga-68 和 Lu-177 一起在人体中应用

Lukas Greifenstein, Annika Gunkel, Aileen Hoehne, Frank Osterkamp, Christiane Smerling, Christian Landvogt, Corinna Mueller, Richard P Baum

MOF-Hosted Enzymes for Continuous Flow Catalysis in Aqueous and Organic Solvents

MOF负载酶在水相和有机溶剂中用于连续流动催化

Greifenstein, Raphael; Ballweg, Tim; Hashem, Tawheed; Gottwald, Eric; Achauer, David; Kirschhöfer, Frank; Nusser, Michael; Brenner-Weiß, Gerald; Sedghamiz, Elaheh; Wenzel, Wolfgang; Mittmann, Esther; Rabe, Kersten S; Niemeyer, Christof M; Franzreb, Matthias; Wöll, Christof

From Automated Synthesis to In Vivo Application in Multiple Types of Cancer-Clinical Results with [(68)Ga]Ga-DATA(5m).SA.FAPi

从自动化合成到多种癌症类型的体内应用——[(68)Ga]Ga-DATA(5m).SA.FAPi 的临床结果

Greifenstein, Lukas; Kramer, Carsten S; Moon, Euy Sung; Rösch, Frank; Klega, Andre; Landvogt, Christian; Müller, Corinna; Baum, Richard P

Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists

利用锕-225标记的生长抑素受体激动剂和拮抗剂进行α-肽受体放射性核素治疗

Shi, Mengqi; Jakobsson, Vivianne; Greifenstein, Lukas; Khong, Pek-Lan; Chen, Xiaoyuan; Baum, Richard P; Zhang, Jingjing

Squaric Acid Bisphposphonates for Theranostics of Bone Metastasis - the Easy DOTA-Zoledronate

方酸双膦酸盐用于骨转移瘤的诊疗一体化——简易DOTA-唑来膦酸

Greifenstein, Lukas; Engelbogen, Nils; Máthé, Domokos; Grus, Tilmann; Rösch, Frank; Bergmann, Ralf

[68Ga]Ga-DATA5m-LM4, a PET Radiotracer in the Diagnosis of SST2R-Positive Tumors: Preclinical and First Clinical Results

[68Ga]Ga-DATA5m-LM4,一种用于诊断 SST2R 阳性肿瘤的 PET 放射性示踪剂:临床前和首批临床结果

Panagiotis Kanellopoulos, Berthold A Nock, Lukas Greifenstein, Richard P Baum, Frank Roesch, Theodosia Maina

Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators

靶向成纤维细胞活化蛋白 (FAP):使用方酰胺偶联双功能 DOTA 和 DATA5m 螯合剂的下一代 PET 放射性示踪剂

Euy Sung Moon, Filipe Elvas, Gwendolyn Vliegen, Stef De Lombaerde, Christel Vangestel, Sven De Bruycker, An Bracke, Elisabeth Eppard, Lukas Greifenstein, Benedikt Klasen, Vasko Kramer, Steven Staelens, Ingrid De Meester, Pieter Van der Veken, Frank Rösch